Lafora Disease

Lafora disease is an inherited neurodegenerative disorder characterized by the presence of abnormal glycogen inclusions, called Lafora bodies, in neurons and other tissues. Here is the latest research on this fatal, autosomal recessive disorder.

April 18, 2020

Early Parkinsonism in a Senegalese girl with Lafora disease

Epileptic Disorders : International Epilepsy Journal with Videotape
Francesca RagonaTiziana Granata
November 24, 2019
Case Report

Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case

Archivos argentinos de pediatría
Gabriela UrmanArnoldo Grosman
June 20, 2020

Measurements of the Timescale and Conformational Space of AMPA Receptor Desensitization

Biophysical Journal
Hector SalazarAndrew J R Plested
June 2, 2020

Polyglucosan body structure in Lafora disease

Carbohydrate Polymers
M Kathryn BrewerMatthew S Gentry
December 22, 2019
Comment / Editorial

Can amyloid PET differentiate "pure" LBD from AD with or without LBD copathology?

Neurology
Susan M Landau, Victor L Villemagne
February 12, 2020

Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jeff SchaffertC Munro Cullum
January 9, 2020

High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases

Journal of Neural Transmission
Anastasia BougeaElisabeth Kapaki
December 22, 2019

Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma

Annals of Diagnostic Pathology
Jayanti JhaSeema Kashyap
July 1, 2020

Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia

Journal of Alzheimer's Disease : JAD
Leonie J M VergouwVincenzo Bonifati
April 29, 2020

A novel compound heterozygous EPM2A mutation in a Chinese boy with Lafora disease

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Yujiao FuHongyu Long
April 5, 2020

The effects of repetitive neck-muscle vibration on postural disturbances after a chronic stroke

Neurophysiologie clinique = Clinical neurophysiology
Karim JamalIsabelle Bonan
June 3, 2020

Ethnic disparities in the uptake of anti-dementia medication in young and late-onset dementia

International Psychogeriatrics
Clarissa GiebelAravind Komuravelli

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/lafora-disease/b098ef21-1186-4dcc-b8ef-6d71ab560538